Elsibucol

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameElsibucol
Drug Alias Name艾赛布可elsibucolumAGI-1096
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular cell adhesion molecule 1 inhibitors
TargetsVascular cell adhesion molecule 1
Therapy Area/IndicationsRejection of organ transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAtherogenics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma IncAtherogenics Inc
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantation

Other Information

ATC CodeN/A
Related LinksN/A